Topic
GLP-1
BBN has covered 7 stories about GLP-1, mostly in U.S. and Weird News, as reported by NPR, Yahoo Health, PharmaVoice, MarketWatch and others. Newest first.
- U.S.
Lawsuits allege GLP-1 harm, but safety data is scant
Pending lawsuits claim GLP-1 drugs caused severe conditions including blindness and pancreatitis, yet manufacturers and regulators lack comprehensive data on how frequently such injuries occur.
Reported by NPR - U.S.
'Ozempic babies' are real, doctors explain GLP-1 fertility
Doctors say GLP-1 weight-loss drugs may alter fertility in some women, prompting medical guidance to discuss the effects with healthcare providers beforehand.
Reported by Yahoo Health - Weird News
Should You Be Worried? HHS Wants Faster Drug Research
HHS is pushing for faster drug development timelines while reports highlight unusual side effects emerging from GLP-1 medications.
Reported by PharmaVoice - U.S.
GLP-1 Drugs May Ease Back and Knee Pain, With Risks
Rapid weight loss from GLP-1 drugs may weaken bone quality in older adults, offsetting joint pain relief benefits.
Reported by MarketWatch - Your Money
India's Food Regulator Acts Against GLP-1 Supplement Over Claims
India's regulator targeted a supplement falsely mimicking prescription GLP-1 drugs; such knockoffs cost monthly but may lack effectiveness, regulators warn.
Reported by Bloomberg.com - U.S.
CBS: Could GLP-1 Drugs Curb Gambling and Shopping Sprees?
A Brown University neuroscientist told CBS that GLP-1 weight-loss drugs might help reduce gambling and shopping addictions, though researchers are still in early stages of exploring the connection.
Reported by CBS News - U.S.
PepsiCo Squeezed by Elliott and GLP-1 Worries
Reported by Investing.com
BBN is a parody news network: the headlines are real and credited to the outlets that reported them; the anchors are fictional and their lines are written by AI. How BBN works.